Neoadjuvant cytokine (IRX-2) immunotherapy for resectable oral cavity carcinoma: Final results of the INSPIRE trial

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Neoadjuvant cytokine (IRX-2) immunotherapy for resectable oral cavity carcinoma: Final results of the INSPIRE trial'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Immunology and Microbiology